Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Taxes × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 85 Triple Negative Breast Neoplasms 34 Breast Neoplasms, Male 17 Inflammatory Breast Neoplasms 7 Neoplasm Metastasis 6 Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Ovarian Epithelial 5 Stomach Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Anatomic Stage I Breast Cancer AJCC v8 4 Sarcoma 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Breast Carcinoma In Situ 2 Anatomic Stage II Breast Cancer AJCC v8 2 Uterine Cervical Neoplasms 1 Thrombocytosis 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma, Ovarian 1

Interventions

Fulvestrant 17 Letrozole 9 Anastrozole 7 Capecitabine 5 olaparib 4 Docetaxel 4 pyrotinib 3 palbociclib 3 Vinorelbine 3 Paclitaxel 3 Goserelin 3 Aromatase Inhibitors 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 exemestane 2 eribulin 2 dalpiciclib 2 Trastuzumab 2 FCN-437c 2 Dasatinib 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 vandetanib 1 talazoparib 1 sonidegib 1 ribociclib 1 neratinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 entinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡